We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 526.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.19%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 526.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Crystallisation of Business Unit & Issue of Shares

20 Nov 2019 13:30

RNS Number : 0949U
Polar Capital Holdings PLC
20 November 2019
 

Polar Capital Holdings plc

20 November 2019

Partial Crystallisation of Business Unit and issue of shares

 

Polar Capital Holdings plc ("Polar Capital" or the "Company") announces the partial crystallisation of a set of Preference Shares held by Andrew Holliman and Richard Wilson, co-heads of the Polar Capital North America Team and managers of the Polar Capital North American Fund. This partial crystallisation is expected to be immediately earnings enhancing for shareholders. Based on the results for the financial year ended 31 March 2019, the impact of the crystallisation would have been an earnings enhancement of around 1p per share1.

 

Background

As set out at the time of the Company's admission to AIM, Polar Capital has structured its fund management operations in such a way that the fund management teams are placed in separate business units. Each business unit is a separate profit centre and the fund managers responsible receive each year a payment which comprises a share of their unit's core operating profit (operating profit before performance fees and related distributions) and performance fees.

 

In addition to the remuneration structure described above, each fund management team is offered the prospect of an interest in the capital of the Company through the purchase of an individual class of preference shares in Polar Capital Partners Limited, a wholly owned subsidiary of the Company. These preference shares have been structured in such a way as to become convertible upon the occurrence of certain events, known as crystallisation events, into cash or, at the option of the Company, ordinary shares at a ratio that is intended to be earnings enhancing for the Group. At the election of the holders of the preference shares, they may crystallise all or part of their preference shares, or retain the balance, if any, for a further crystallising event at a subsequent date.

 

From the effective date of crystallisation, the fund managers concerned cease to be eligible to receive a proportion of their share of the business unit's core operating profit which has been crystallised and simultaneously going forward will receive a proportionally reduced interest in their performance fees.

 

 

North American Team business unit crystallisation

Andrew Holliman and Richard Wilson have elected to crystallise one third of their preference shares in relation to the Polar Capital North American Fund.

 

Under the terms of the preference shares the partial crystallisation value is calculated as at 31 March 2019 and either satisfied in cash, or at the option of the Company, by issue of new ordinary shares. The Company has elected to satisfy the consideration by the issue of new ordinary shares.

 

The partial crystallisation is in relation to the crystallisation period ended 31 March 2019. The initial crystallisation value is to be satisfied by the issue of up to 1,442,064 new ordinary shares, in tranches as described below. This value is re-calculated at each of the first, second, and third anniversaries of 31 March 2019, based on the profits of the business unit in the 12 months ended on the respective anniversary. If the result of the re-calculation provides for a smaller cash or share consideration, then the amounts paid or shares issued to the owners of the preference shares are adjusted accordingly. The effect of such re-calculation is to adjust downwards any consideration and there can never be an increase in the Crystallisation Value. In return for this delivery of new ordinary shares, the North American team will be forfeiting one third of the interest in their core operating profit in relation to the Polar Capital North American Fund for the financial year ended 31 March 2019.

 

Under the terms of the preference shares 10 percent of the new ordinary shares are issued immediately with the balance of 30 percent of the new ordinary shares due (subject to the re-calculation described above) on or as soon as practicable after each crystallisation anniversary.

 

As a result, the Company will issue a total of 144,206 new ordinary shares in respect of this partial crystallisation which will rank pari passu with the Company's existing ordinary shares at the time of issue.

 

The Company's current issued share capital is 96,464,735 ordinary shares and following admission of the new ordinary shares the total ordinary shares in issue will be 96,608,941.

 

Mr Holliman and Mr Wilson retain two-thirds of their class of preference shares which remain convertible upon certain future events and reflect the continued economic interest that the managers have in the North American business unit.

 

1 Presented for illustrative purposes based on the year end results for 31 March 2019 and assuming the partial crystallisation occurred as at 31 March 2019.

 

For further information please contact:

Polar Capital +44 (0)20 7227 2700

Gavin Rochussen (Chief Executive)

John Mansell (Executive Director)

Samir Ayub (Finance Director)

 

Numis Securities Limited - Nomad and Joint Broker +44 (0)20 7260 1000

Charles Farquhar

Stephen Westgate

Kevin Cruickshank (QE)

 

Peel Hunt LLP - Joint Broker +44 (0)20 7418 8893

Guy Wiehahn

Andrew Buchanan

 

Camarco +44 (0)20 7757 4995

Ed Gascoigne-Pees

Monique Perks

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEADFEAAXNFFF
Date   Source Headline
26th Nov 20187:00 amRNSUnaudited Interim Results
22nd Nov 20185:00 pmRNSDirectorate Change
5th Nov 20187:01 amRNSNotice of Results
5th Nov 20187:00 amRNSChange of Nominated Adviser and Broker
1st Nov 20187:00 amRNSTotal Voting Rights
25th Oct 20185:26 pmRNSIssue of Equity
24th Oct 20184:52 pmRNSDirector/PDMR Shareholding
17th Oct 20185:49 pmRNSIssue of Equity
15th Oct 201812:38 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
12th Oct 20182:52 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
11th Oct 20184:42 pmRNSIssue of Equity
11th Oct 20187:01 amRNSCrystallisation of business unit & issue of shares
11th Oct 20187:00 amRNSAUM Update
3rd Oct 201810:24 amRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
19th Sep 201811:52 amRNSForm 8.3 - Jardine Lloyd Thompson Group
18th Sep 201812:02 pmRNSForm 8.3 - Realm Therapeutics PLC
17th Aug 20189:27 amRNSDirectorate Change
6th Aug 20187:00 amRNSBlock listing Interim Review
1st Aug 20187:00 amRNSTotal Voting Rights
31st Jul 20185:57 pmRNSIssue of Equity
31st Jul 201811:29 amRNSDirector/PDMR Shareholding
25th Jul 20183:38 pmRNSDirectorate Change
25th Jul 20183:26 pmRNSResult of AGM
19th Jul 201811:13 amRNSForm 8.3 - Consort Medical Plc
18th Jul 20184:21 pmRNSDirector/PDMR Shareholding
18th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
17th Jul 201810:58 amRNSForm 8.3 - Consort Medical Plc
16th Jul 20183:44 pmRNSDirector/PDMR Shareholding
12th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
12th Jul 20187:00 amRNSAuM Update
11th Jul 201811:06 amRNSForm 8.3 - Consort Medical Plc
3rd Jul 20186:27 pmRNSHolding(s) in Company
3rd Jul 20186:20 pmRNSIssue of Equity
3rd Jul 201812:07 pmRNSForm 8.3 - Consort Medical Plc
2nd Jul 201810:23 amRNSTotal Voting Rights
29th Jun 20187:00 amRNSBlock Listing Application
28th Jun 20185:55 pmRNSAnnual Financial Report
25th Jun 20187:00 amRNSGroup Audited Results for year ended 31 March 2018
11th Jun 201811:27 amRNSNet Asset Value(s)
1st Jun 20187:41 amRNSTotal Voting Rights
24th May 201810:59 amRNSDirector/PDMR Shareholding
24th May 20189:35 amRNSIssue of Equity
23rd May 201811:00 amRNSNotice of Results
23rd May 20189:37 amRNSIssue of Equity
18th May 20181:02 pmRNSIssue of Equity
16th May 20185:49 pmRNSIssue of Equity
11th May 20187:00 amRNSIssue of Equity
10th May 20189:56 amRNSDirector/PDMR Shareholding
1st May 20183:52 pmRNSIssue of Equity
12th Apr 20187:00 amRNSAuM Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.